The role of interleukin-6 in the activation of the hypothalamo- pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1β

Brain Research

Volumn 815, Issue 2, 1999, Pages 337-348

  Wang, Jianping ^a   Dunn, Adrian J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

ACTH; Corticosterone; Interleukin 1; Interleukin 6; Lipopolysaccharide; Serotonin; Tryptophan

Indexed keywords

CORTICOSTERONE; INDOLEAMINE; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; SEROTONIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; MOUSE; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEROTONINERGIC SYSTEM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIBODIES, MONOCLONAL; BIOGENIC AMINES; BRAIN; CORTICOSTERONE; ENDOTOXINS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOLES; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; PITUITARY-ADRENAL SYSTEM;

EID: 0033537337     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01091-9     Document Type: Article

References (46)

1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
2. Besedovsky H.O., del Rey A., Klusman I., Furukawa H., Monge Arditi G., Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40:1991;613-618.
3. Besedovsky H.O., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 233:1986;652-654.
4. Bocci V. Interleukins: clinical pharmacokinetics and practical implications. Clin. Pharmacokinet. 21:1991;274-284.
5. Derijk R., Van Rooijen N., Tilders F.J.H., Besedovsky H.O., Del Rey A., Berkenbosch F. Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology. 128:1991;330-338.
6. Dunn A.J. Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone. J. Neurochem. 51:1988;406-412.
7. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261:1992;964-969.
8. Dunn A.J. The role of interleukin-1 and tumor necrosis factor α in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29:1992;807-812.
9. A.J. Dunn, Neurochemical methods for evaluating cerebral biogenic amine responses to cytokines and their involvement in the central actions of interleukin-1, in: E.B. De Souza (Ed.), Neurobiology of Cytokines: Part B, Vol. 17, Academic Press, San Diego (1993) pp. 209-222.
10. A.J. Dunn, Effects of the interleukin-1 (IL-1) receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice, Neuroimmunomodulation, submitted for publication.
11. Dunn A.J., Wang J. Cytokine effects on CNS biogenic amines. Neuroimmunomodulation. 2:1996;319-328.
12. Elenkov I.J., Kovacs K., Kiss J., Bertok L., Vizi E.S. Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels - evidence from rats with lesions of the paraventricular nucleus. J. Endocrinol. 133:1992;231-236.
13. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1994;1243-1250.
14. Givalois L., Dornand J., Mekaouche M., Solier M.D., Bristow A.F., Ixart G., Siaud P., Assenmacher I., Barbanel G. Temporal cascade of plasma level surges in ACTH and corticosterone and cytokines in endotoxin-challenged rats. Am. J. Physiol. 267:1994;R164-170.
15. Granowitz E.V., Porat R., Mier J.E., Pribble J.P., Stiles D.M., Bloedow D.C., Catalano M.A., Wolff S.M., Dinarello C.A. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokines. 4:1992;353-360.
16. Heremans H., Dillen C., Put W., Van Damme J., Billiau A. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur. J. Immunol. 22:1992;2395-2401.
17. Heyes M.P., Quearry B.J., Markey S.P. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res. 491:1989;173-179.
18. Hoogenraad N.J., Wraight C.J. The effect of pristane on ascites tumor formation and monoclonal antibody production. Methods Enzymol. 121:1986;375-381.
19. Kimura H., Ishibashi T., Shikama Y., Okano A., Akiyama Y., Uchida T., Maruyama Y. Interleukin-1β (IL-1β) induces thrombocytosis in mice: possible implication of IL-6. Blood. 76:1990;2493-2500.
20. Layé S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 27:1994;157-162.
21. Libert C., Brouckaert P., Shaw A., Fiers W. Induction of interleukin-6 by human and murine recombinant interleukin-1 in mice. Eur. J. Immunol. 20:1990;691-694.
22. Libert C., Vink A., Coulie P., Brouckaert P., Everaerdt B., Van Snick J., Fiers W. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur. J. Immunol. 22:1992;2625-2630.
23. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77:1993;1690-1694.
24. Matta S.G., Weatherbee J., Sharp B.M. A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1β Neuroendocrinology. 56:1992;516-525.
25. May L.T., Neta R., Moldawer L.L., Kenney J.S., Patel K., Sehgal P.B. Antibodies chaperone circulating IL-6. J. Immunology. 151:1993;3225-3236.
26. Muramami N., Fukata J., Tsukada T., Kobayashi H., Ebisui O., Segawa H., Muro S., Imura H., Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland and spleen. Endocrinology. 133:1993;2574-2578.
27. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Commun. 155:1988;1459-1463.
28. Perlstein R.S., Whitnall M.H., Abrams J.S., Mougey E.H., Neta R. Synergistic roles of interleukin-6, interleukin-1 and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology. 132:1993;946-952.
29. Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front. Neuroendocrinol. 16:1995;151-182.
30. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 125:1989;2800-2805.
31. Romero L.I., Schettini G., Lechan R.M., Dinarello C.A., Reichlin S. Bacterial lipopolysaccharide induction of IL-6 in rat telencephalic cells is mediated in part by IL-1. Neuroendocrinology. 57:1993;892-897.
32. Roth J., Conn C.A., Kluger M.J., Zeisberger E. Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am. J. Physiol. 265:1993;R653-R658.
33. Schöbitz B., Van Den Dobbelsteen M., Holsboer F., Sutanto N., de Kloet E.R. Regulation of interleukin 6 gene expression in rat. Endocrinology. 132:1993;1569-1576.
34. Schotanus K., Tilders F.J.H., Berkenbosch F. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats. Endocrinology. 133:1993;2461-2468.
35. Sébire G., Emilie D., Wallon C., Héry C., Devergne O., Delfraissy J.-F., Galanaud P., Tardieu M. In vitro production of IL-6, IL-1β and tumor necrosis factor-α by human embryonic microglial and neural cells. J. Immunol. 150:1993;1517-1523.
36. Shalaby M.R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53:1989;488-498.
37. Strassmann G., Fong M., Windsor S., Neta R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine. 5:1993;285-290.
38. Strassmann G., Kambayashi T. Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy. Cytokines Mol. Ther. 1:1995;107-113.
39. Tilders F.J.H., DeRijk R.H., Van Dam A.-M., Vincent V.A.M., Schotanus K., Persoons J.H.A. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology. 19:1994;209-232.
40. Turnbull A.V., Dow R.C., Hopkins S.J., White A., Fink G., Rothwell N.J. Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat. Psychoneuroendocrinology. 19:1994;165-178.
41. Vallières L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β J. Neurochem. 69:1997;1668-1683.
42. Vink A., Coulie P., Warnier G., Renauld J.-C., Stevens M., Donckers D., Van Snick J. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J. Exp. Med. 172:1990;997-1000.
43. Wang J.P., Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 33:1998;143-154.
44. Wang Q., Fischer J.E., Hasselgren P.O. Treatment of endotoxic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis. Arch. Surg. 132:1997;82-88.
45. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 643:1994;40-49.
46. Zuckerman S.H., Shellhaas J., Butler L.D. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur. J. Immunol. 19:1989;301-305.